Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02612207 · ClinicalTrials.gov registry record
Point-of-Care System for Determination of Bilirubin Capacity in Neonates
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 161
- Enrollment target
NCT02612207: Completed study, sponsored by Stanford University.
NCT02612207 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 161 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02612207 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 161 participants
- Enrollment target
Study Summary
The aims of this observational bench project are to validate the performance of the miniaturized and modernized hematofluorometer that measures bilirubin capacity into a product and is suitable for operation in various point of care environments w in the management of preterm neonates.
Interventions
- DEVICE Bilirubin Binding Capacity by Hematofluorometry Validation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 161 participants |
| Start Date | 2015-08-01 |
| Est. Completion | 2018-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02612207
The ClinicalTrials.gov registry entry for NCT02612207 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 161 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bilirubin Binding Capacity by Hematofluorometry Validation is the first listed.
NCT02612207 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02612207 about?
NCT02612207 is a clinical study titled "Point-of-Care System for Determination of Bilirubin Capacity in Neonates". The aims of this observational bench project are to validate the performance of the miniaturized and modernized hematofluorometer that measures bilirubin capacity into a product and is suitable for operation in various point of care environments w in the management of preterm neonates.
What is the current status of trial NCT02612207?
This trial is currently completed. The enrollment target is 161 participants. The study started on 2015-08-01. Estimated completion is 2018-08-31.
What interventions are being tested in trial NCT02612207?
The interventions under investigation include: Bilirubin Binding Capacity by Hematofluorometry Validation (DEVICE).
Who is sponsoring clinical trial NCT02612207?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.